Mangrove Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Green Plains
GPRE
|
+$25.3M |
| 2 |
SunCoke Energy
SXC
|
+$21.3M |
| 3 |
NIHD
NII Holdings, Inc. Common Stock
NIHD
|
+$12.9M |
| 4 |
GrafTech
EAF
|
+$11.3M |
| 5 |
CCX.U
Churchill Capital Corp II
CCX.U
|
+$8.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STML
Stemline Therapeutics, Inc.
STML
|
+$8.18M |
| 2 |
Savara
SVRA
|
+$6M |
| 3 |
LVOXU
LiveVox Holding, Inc. Unit
LVOXU
|
+$4M |
| 4 |
TRNE.U
Trine Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of
TRNE.U
|
+$3.51M |
| 5 |
Repay Holdings
RPAY
|
+$3.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 24.72% |
| 2 | Industrials | 13.91% |
| 3 | Healthcare | 9.99% |
| 4 | Materials | 9.92% |
| 5 | Communication Services | 9.41% |
Similar funds
Mangrove Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Mangrove Partners held 102 positions worth $885M, up 18% from $748M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Mangrove Partners deployed $160M of net new capital in Q2 2019, opening 30 new positions and adding to 15 existing holdings. Its largest new stake was NII Holdings, Inc. Common Stock: 6,776,506 shares worth $11.5M.
By sector, the portfolio is most concentrated in Energy at 25% of assets, down from 34% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Collier Creek Holdings Warrants, each whole warrant exercisable for one Class A ordinary share at an, an estimated $61K trimmed.
- Mangrove Partners's largest Q2 2019 buy was NII Holdings, Inc. Common Stock: 6,776,506 shares worth $11.5M.
- Mangrove Partners added most to Green Plains in Q2 2019, an estimated $25.3M increase.
- Mangrove Partners's biggest Q2 2019 reduction was Collier Creek Holdings Warrants, each whole warrant exercisable for one Class A ordinary share at an, cutting an estimated $61K.
- Mangrove Partners fully exited Stemline Therapeutics, Inc. in Q2 2019, selling an estimated $8.18M.
- Mangrove Partners's ten largest holdings make up 53% of its $885M portfolio in Q2 2019.
- Mangrove Partners opened 30 new positions and closed 15 in Q2 2019.
- Mangrove Partners's portfolio value rose 18% quarter-over-quarter to $885M.
Based on Mangrove Partners's 13F filing for Q2 2019, filed 14 Aug 2019.